EUCTR2019-004125-24-NL进行中（未招募）1 期
Reduced Anticoagulation Targets in Extracorporeal life support - RATE
MCG0 个研究点目标入组 330 人开始时间: 2020年7月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 330
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adults with heart or lungfailure treated with ECMO
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •Vital indication for robust anticoagulation (e.g. mechanical mitral valvae) or contraindication for heparin (e.g. HIT)
研究者
相似试验
尚未招募
不适用
Reduced Anticoagulation Targets in Extracorporeal life supportHeart or lungfailureNL-OMON22774niversity Medical Center Groningen (UMCG)330
招募中
3 期
Reduced Anticoagulation Targets in Extracorporeal life supportHeart or lungfailure1001928010024970NL-OMON50046niversitair Medisch Centrum Groningen330
招募中
3 期
The effect of systemic anticoagulants in repairing penetrating upper limb arterial traumaArterial trauma.I23.6IRCT20190717044255N3Arak University of Medical Sciences116
撤回
不适用
New Anticoagulation Strategies of VV-ECMOHemorrhageNCT03497338Xiao Tang
尚未招募
3 期
Investigating the effectiveness of anticoagulants compared to aspirin and clopidogrel on disease severity in patients with ischemic stroke.Cerebral infarctionIRCT20221026056307N1Bojnourd University of Medical Sciences86